Tyra Biosciences, Inc.·4

Oct 2, 5:38 PM ET

Harris Todd 4

4 · Tyra Biosciences, Inc. · Filed Oct 2, 2024

Insider Transaction Report

Form 4
Period: 2024-09-30
Harris Todd
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2024-09-30$24.00/sh500$12,0001,477,373 total
Footnotes (1)
  • [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4